Streetbeat News

Earnings

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) reported positive Phase 2 results for its Alzheimer's drug, CT1812. Participants in the study showed cognitive improvement compared to placebo across various measures. The findings were presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:05 am

ARLP

Alliance Resource Partners (NASDAQ: ARLP) reported Q2 2024 earnings of $0.77 per share, missing the analyst estimate of $0.95. Sales were $593.35 million, below the $632.338 million estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:04 am

MCD

McDonald's shares are trading lower following worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:02 am

OIS

Oil States International (NYSE:OIS) reported Q2 2024 earnings of $0.07 per share, beating the analyst estimate of $0.04 by 75%. Sales were $186.383M, surpassing the $179.629M estimate. This represents a 600% increase in EPS and a 1.56% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:02 am

AMG

Affiliated Managers Group (NYSE: AMG) reported Q2 2024 adjusted EPS of $4.67, beating the estimate of $4.61. However, sales of $500.3M missed the $518.027M estimate and decreased by 2.38% from last year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:02 am

MCD

McDonald's Q2 global comparable sales decreased by 1%, reflecting negative comparable sales across all segments.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:01 am

MCD

McDonald's (NYSE:MCD) reported Q2 2024 earnings per share of $2.97, missing the analyst estimate of $3.07. Quarterly sales were $6.490 billion, also missing the estimate of $6.608 billion. Sales decreased by 0.12% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:00 am

LGVN

Longeveron shares are trading higher following the announcement of positive study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease. The trial met its key objectives, supporting a favorable benefit/risk profile.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:59 am

AAPL

FND

LMT

RSG

TYL

Top Wall Street analysts with high accuracy rates have made recent stock picks, including Apple, Floor & Decor, Republic Services, Tyler Technologies, and Lockheed Martin. These picks are based on recent ratings and financial results.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 10:50 am

INSP

Inspire Medical Systems announced preliminary Q2 revenue of $195.9 million, surpassing the estimated $186.3 million. This represents a 30% increase over the same quarter of 2023, with U.S. revenue at $187.8 million and international revenue at $8.1 million.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:47 am